Elizabeth Berry-Kravis is professor of child neurology at Rush University Medical Center in Chicago.
Elizabeth Berry-Kravis
Professor
Rush University Medical Center
From this contributor
Analysis offers new hope for failed fragile X drug
Eye tracking shows that mavoglurant, a once-abandoned experimental drug for fragile X syndrome, enters the brain and boosts social interest, says Elizabeth Berry-Kravis.
Analysis offers new hope for failed fragile X drug
By
Jessica Wright
26 February 2019 | 6 min read
Questions for Elizabeth Berry-Kravis: Dodging mouse traps
A mouse model of fragile X syndrome lacks a key feature of the condition, prompting researchers to look for other ways to test treatments.
Questions for Elizabeth Berry-Kravis: Dodging mouse traps
By
Jessica Wright
24 May 2016 | 6 min read
Questions for Elizabeth Berry-Kravis: Measuring drug effects
Drugs designed to treat fragile X syndrome have yet to show substantial benefits in people. But rather than abandon them, child neurologist Elizabeth Berry-Kravis suggests a new way to measure their effectiveness.
Questions for Elizabeth Berry-Kravis: Measuring drug effects
By
Nicholette Zeliadt
17 February 2015 | 5 min read
Explore more from The Transmitter
Fruit flies use memory to track odors
When flies encounter a tasty smell, they stroll in and out of the odor plume—a process that depends on encoding a memory of the angle needed to travel back to the plume, according to a new study.
Fruit flies use memory to track odors
When flies encounter a tasty smell, they stroll in and out of the odor plume—a process that depends on encoding a memory of the angle needed to travel back to the plume, according to a new study.
By
Calli McMurray
8 September 2026 | 2 min watch
New methods to contextualize autism-linked genes, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 7 September.
New methods to contextualize autism-linked genes, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 7 September.
By
Jill Adams
8 September 2026 | 2 min read
Dimensionality—neuroscience’s red herring?
Placing too much emphasis on a specific interpretation of dimensionality, or treating it as an end-all quantification of some aspect of neural computation, may hinder progress in understanding the brain.
Dimensionality—neuroscience’s red herring?
Placing too much emphasis on a specific interpretation of dimensionality, or treating it as an end-all quantification of some aspect of neural computation, may hinder progress in understanding the brain.
By
Matthew Perich
7 September 2026 | 8 min read